Page 12 - AN-1-1
P. 12

Advanced Neurology                                                          AIS in patients with COVID-19




                    Male, n   (%)  243 (54.85)  21 (42.0)  373 (83.8)  1571 (51.3)  13 (48)  130 (49.6)  11183   (50.3)   11 (57.9)   168 (77.8)   13 (56.5)  NA  67 (67.0)  111 (63)  20 (58.8)  -  150 (68.2)   (Contd...)


                 COVID-19 negative  Age, mean [SD]   or median [IQR]   (years)  68.34 (14.5)  72.9 (12.8)  72 (60 – 80)  NA  72 (60 – 81.5)  74 (61 – 80)  70.5 (13.7)  71.0 (15.9)  54.9 (14.1)  68.3 (13.69)  NA  NA  68.1 (14.4)  70.3 (15.3)  -  58.7 (14.5)







                    Sample   Size  444  48  445  3061  27  262  22217  19  216  23  544  100  176  34  -  220



                    Male, n   (%)  60 (59.41)  15(65.5)  8 (61.5)  71 (68.3)  8 (80)  24 (70.6)  1167 (55)   6 (60.0)  28 (87.5)   5 (38.5)  NA  51 (65.4)  25 (62)  10 (83.3)  18 (78.3)  18 (94.7)


                 COVID-19 positive  Age, mean   [SD] or median   [IQR] (years)  68.19 (13.3)  74.5 (7.9)  58 (50 – 71)  NA  59.5 (54 – 71.5)  76 (63 – 82.25)  69.8 (13.5)  70.8 (14.8)  48.9 (11.5)  63 (11.87)  NA  NA  64.8 (13.5)  60.1 (12.6)  66.9 (11.8)  48.1 (10.8)






                    Sample   size  101  22  13  104  10  34  2122  10  32  13  22    78  40   12  23     19




                 Study period  18 February 19 – 31   December 20  15 September 20 –   30 November 20  February –March or   March – April 20  1 April – 31 July 20  1 March 20 – 15   April 20  8 March – 30 April   20  1 December 19 – 1   January 21  2 March – 30 April   20  March – May 20  1 March – 17   April 20  January – April 20  4 April – 15   September 20  17 March – 2 May 2   20  15 March – 30   April 20  1 March – 19 April   20  1 March – 10   May 20






                 Confirmation   of COVID-19  PCR  RT-PCR  RT-PCR  WHO   Guideline   RT-PCR  RT-PCR  Not specified  RT-PCR  Not specified  RT-PCR  PCR  RT-PCR  PCR  RT-PCR  WHO   Guideline  PCR





                 Continent  Asia,   Europe  Europe  North   America,   South   America,    Europe  North   America  Europe   Europe  North   America  Europe  Asia  North   America  North   America,   Europe  Asia  Europe  Europe  Europe  Asia



             Table 1. Characteristics of the included studies.
                 Country  Iran, Greece,   Germany  Poland  North America,   South America,    Europe  USA  France  Italy  USA  Spain  Qatar  USA  UK, USA  India  France  France  Spain  The United   Arab Emirates






                 Design   Prospective   cohort  Retrospective   cohort  Prospective   cohort  Retrospective   cohort  Prospective   cohort  Prospective   cohort  Retrospective   cohort  Retrospective   cohort  Prospective   cohort  Retrospective   cohort  cross-sectional  Retrospective   cohort  Retrospective   cohort  Prospective   cohort  Retrospective   cohort  Retrospective   cohort


                 Year     2021  2021  2020    2020  2020  2021  2021  2020  2021  2020  2020  2021  2021  2020  2020  2020



                 Author   Sasanejad   et al.  Sobolewski   et al.  Kasab et al.  Havenon   et al.  Escalard    et al. -1  Pezzini et al.  Qureshi    et al. -1  Requena   et al.  Akhtar et al.  Altschul et al.  Bekelis et al.  Benny et al.  Calmettes   et al.  Escalard    et al. -2  Herna´ndez-  Ferna´ndez   et al.  John et al.




            Volume 1 Issue 1 (2022)                         4                        https://doi.org/10.36922/an.v1i1.28
   7   8   9   10   11   12   13   14   15   16   17